Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy

livescience - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

AI Summary: An experimental treatment markedly cut seizures and eased symptoms in children with Dravet syndrome, offering families dramatic improvements where few options existed. Early clinical data show promising safety and efficacy signals, but researchers caution larger, longer trials and regulatory review are needed before this becomes a routine option.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

FDA approves Rocket Pharma gene therapy for ultra‑rare immune disorder / 2 months

Pediatricians’ immune cells yield antibody cocktail protecting against RSV and hMPV / 3 months

FDA Lifts Hold on Intellia’s Phase 3 Gene Editing Trial / 4 months

FDA rejects Corcept’s cortisol modulator triggering setback / 4 months

FDA approves Rucaparib for advanced prostate cancer / 5 months

FDA approves first gene therapy for Wiskott‐Aldrich syndrome / 5 months

FDA Approves Novartis’ Itvisma Gene Therapy for SMA Across Age Groups / 5 months